Search Results 551-560 of 18579 for alopecia
Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn., Albert Lea, Minn ...
... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...
... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Nonmelanoma skin cancer, Tuberous sclerosis ...
Natural History Evaluation Among Female Breast Cancer Survivors With Endocrine Therapy-Induced Alopecia. Mankato, Minn., Rochester, Minn., Albert Lea, Minn ...
Has unresolved clinically significant adverse events ≥ grade 2 from prior anticancer therapy, except for alopecia or anemia. Had major surgery within 21 ...
Residual chronic toxicities of prior therapy ≤ Grade 2 (eg, peripheral neuropathy, residual alopecia) are allowed. Female subjects who are pre-menopausal ...
... alopecia not requiring systemic treatment, conditions not expected to recur in the absence of an external trigger. Patients with a history of organ ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.